Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Bradykinesia

1-(3-chlorophenyl)piperazine has been researched along with Bradykinesia in 1 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Research Excerpts

ExcerptRelevanceReference
" In the present study, we investigated whether chronic administration of fluvoxamine desensitizes 5-HT2C receptors using a putative in vivo rat model of 5-HT2C receptor function."1.32Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats. ( Imanishi, T; Kojima, M; Nagase, K; Tatebayashi, T; Yamauchi, M, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamauchi, M1
Tatebayashi, T1
Nagase, K1
Kojima, M1
Imanishi, T1

Other Studies

1 other study available for 1-(3-chlorophenyl)piperazine and Bradykinesia

ArticleYear
Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Pharmacology, biochemistry, and behavior, 2004, Volume: 78, Issue:4

    Topics: Animals; Brain; Dose-Response Relationship, Drug; Fluvoxamine; Hypokinesia; Male; Motor Activity; Pa

2004